Whole-body MR/PET: Applications in abdominal imaging

Abdominal Imaging

Volumn 37, Issue 1, 2012, Pages 20-28

  Schwenzer, N F ^a   Schmidt, H ^a   Claussen, C D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Abdominal imaging; Hybrid imaging; MR PET; MRI; PET; Simultaneous

Indexed keywords

BISMUTH GERMINATE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; LUTETIUM OXYORTHOSILICATE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ABDOMEN; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; WHOLE BODY IMAGING; WORKFLOW;

ABDOMEN; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 84858708392     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9809-7     Document Type: Review

References (48)

1. Catana C, Procissi D, Wu Y, et al. (2008) Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci USA 105:3705-3710 (Pubitemid 351723462)
2. Judenhofer MS, Wehrl HF, Newport DF, et al. (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14:459-465 (Pubitemid 351499385)
3. Pichler BJ, Judenhofer MS, Catana C, et al. (2006) Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med 47:639-647 (Pubitemid 46768465)
4. Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):S56-S68
5. Schlemmer HP, Pichler BJ, Schmand M, et al. (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248:1028-1035
6. Bisdas S, Nagele T, Schlemmer HP, et al. (2010) Switching on the lights for real-time multimodality tumor neuroimaging: The integrated positron-emission tomography/MR imaging system. AJNR Am J Neuroradiol 31:610-614
7. Boss A, Bisdas S, Kolb A, et al. (2010) Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med 51:1198-1205
8. Boss A, Kolb A, Hofmann M, et al. (2010) Diffusion tensor imaging in a human PET/MR hybrid system. Invest Radiol 45:270-274
9. Boss A, Stegger L, Bisdas S, et al. (2011) Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol 21(7):1439-1446
10. Schlemmer HP, Pichler BJ, Krieg R, Heiss WD (2009) An integrated MR/PET system: prospective applications. Abdom Imaging 34:668-674
11. Pichler BJ, Wehrl HF, Judenhofer MS (2008) Latest advances in molecular imaging instrumentation. J Nucl Med 49(Suppl 2):5S-23S (Pubitemid 351948034)
12. Kolb A, Lorenz E, Judenhofer MS, et al. (2010) Evaluation of Geiger-mode APDs for PET block detector designs. Phys Med Biol 55:1815-1832
13. Pichler B, Lorenz E, Mirzoyan R, et al. (1997) Performance test of a LSO-APD PET module in a 9.4 Tesla magnet. IEEE Nucl Sci Symp 2:1237-1239
14. Probst S, Seltzer A, Spieler B, Chachoua A, Friedman K (2011) The appearance of cardiac metastasis from squamous cell carcinoma of the lung on F-18 FDG PET/CT and post hoc PET/MRI. Clin Nucl Med 36:311-312
15. Small GR, Ruddy TD (2011) PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality? J Nucl Cardiol 18:717-728
16. Vermeltfoort IA, Raijmakers PG, Lubberink M, et al. (2011) Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography. J Nucl Cardiol 18:650-656
17. Ewelt C, Floeth FW, Felsberg J, et al. (2011) Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 113:541-547
18. Makino K, Hirai T, Nakamura H, et al. (2011) Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med 25:432-438
19. Rottenburger C, Hentschel M, Kelly T, et al. (2011) Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study. Clin Nucl Med 36:639-642
20. Padhani AR, Krohn KA, Lewis JS, Alber M (2007) Imaging oxygenation of human tumours. Eur Radiol 17:861-872 (Pubitemid 46772763)
21. Cai W, Chen K, Mohamedali KA, et al. (2006) PET of vascular endothelial growth factor receptor expression. J Nucl Med 47: 2048-2056 (Pubitemid 47544993)
22. Chen K, Cai W, Li ZB, Wang H, Chen X (2009) Quantitative PET imaging of VEGF receptor expression. Mol Imaging Biol 11:15-22
23. Sorensen M, Frisch K, Bender D, Keiding S (2011) The potential use of 2-[(18)F]fluoro-2-deoxy-d:-galactose as a PET/CT tracer for detection of hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 38:1723-1731
24. Coombs BD, Szumowski J, Coshow W (1997) Two-point Dixon technique for water-fat signal decomposition with B0 inhomogeneity correction. Magn Reson Med 38:884-889 (Pubitemid 27508631)
25. Martinez-Moller A, Souvatzoglou M, Delso G, et al. (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 50:520-526
26. Hofmann M, Steinke F, Scheel V, et al. (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49:1875-1883
27. Hofmann M, Bezrukov I (2011) MR-based attenuation correction for whole-body PET/MR - quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med 52:1392-1399
28. Kitajima K, Nakamoto Y, Okizuka H, et al. (2008) Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors. Ann Nucl Med 22:595-602
29. Dellestable P, Granel-Brocard F, Rat AC, et al. (2011) Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT. Ann Dermatol Venereol 138:377-383
30. Aukema TS, Olmos RA, Korse CM, et al. (2010) Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up. Ann Surg Oncol 17:1657-1661
31. Pfannenberg C, Aschoff P, Schanz S, et al. (2007) Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43:557-564 (Pubitemid 46177588)
32. Punwani S, Taylor SA, Bainbridge A, et al. (2010) Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 255:182-190
33. Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, et al. (2011) Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma - a pilot study: comparison with 2-deoxy-2-fluoro-d-glucose-positron emission tomography/computed tomography. NMR Biomed. doi:10.1002/nbm.1689
34. van Ufford HM, Kwee TC, Beek FJ, et al. (2011) Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. AJR Am J Roentgenol 196:662-669
35. Lutje S, de Rooy JW, Croockewit S, et al. (2009) Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol 88:1161-1168
36. Lin C, Luciani A, Itti E, Haioun C, Rahmouni A (2007) Whole body MRI and PET/CT in haematological malignancies. Cancer Imaging 7 Spec No A:S88-S93
37. Shortt CP, Gleeson TG, Breen KA, et al. (2009) Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. AJR Am J Roentgenol 192:980-986
38. Heusner T, Golitz P, Hamami M, et al. (2011) "One-stop- shop"staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Eur J Radiol 78:430-435
39. Takenaka D, Ohno Y, Matsumoto K, et al. (2009) Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 30:298-308
40. Luboldt W, Kufer R, Blumstein N, et al. (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249:1017-1025
41. Eschmann SM, Pfannenberg AC, Rieger A, et al. (2007) Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin 46:161-168 (quiz N147-168)
42. Yi CA, Shin KM, Lee KS, et al. (2008) Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 248:632-642
43. Ohno Y, Koyama H, Onishi Y, et al. (2008) Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248:643-654
44. Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ (2006) Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 11:58-65 (Pubitemid 43336943)
45. Ambrosini V, Campana D, Bodei L, et al. (2010) 68 Ga-DOTA-NOC PET/CT clinical impact in patients with neuroendocrine tumors. J Nucl Med 51:669-673
46. Mayo SC, de Jong MC, Bloomston M, et al. (2011) Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. doi:10.1245/s10434-011-1832-y
47. Ruf J, Heuck F, Schiefer J, et al. (2010) Impact of Multiphase 68 Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology 91:101-109
48. Sarmiento JM, Que FG (2003) Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 12:231-242 (Pubitemid 36210867)